| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
178,600,000 |
| Market
Cap: |
226.82(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8901 - $1.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 7.4 |
| Insider 3/6 Months : 8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
| Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
| Total People Bought |
0 |
1 |
4 |
8 |
| Total Buy Transactions |
0 |
1 |
6 |
12 |
| Total Shares Sold |
0 |
96,686 |
455,706 |
719,367 |
| Total Sell Value |
$0 |
$136,327 |
$650,097 |
$1,021,712 |
| Total People Sold |
0 |
1 |
6 |
6 |
| Total Sell Transactions |
0 |
1 |
21 |
26 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Turley James S |
Director |
– • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,837 |
428,735 |
|
- |
|
| Frank Steven |
Director |
– • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,837 |
989,195 |
|
- |
|
| Alvarez Cesar L |
Director |
– • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,837 |
526,227 |
|
- |
|
| Gupta Vinita D |
Director |
– • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,837 |
408,567 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2023-12-28 |
4 |
S |
$1.41 |
$136,327 |
D/D |
(96,686) |
238,275 |
|
9% |
|
| Kirk Randal J |
|
– • • |
2023-12-28 |
4 |
B |
$1.41 |
$136,327 |
I/I |
96,686 |
1,096,686 |
0.01 |
-9% |
|
| Mitchell Dean J |
Director |
– • – |
2023-09-22 |
4 |
B |
$1.41 |
$35,250 |
D/D |
25,000 |
356,836 |
2.39 |
- |
|
| Sabzevari Helen |
President and CEO |
• • – |
2023-08-25 |
4 |
AS |
$1.53 |
$117,763 |
D/D |
(76,969) |
1,560,004 |
|
-24% |
|
| Thomasian Harry Jr. |
Chief Financial Officer |
• – – |
2023-08-24 |
4 |
AS |
$1.64 |
$14,834 |
D/D |
(9,045) |
161,051 |
|
-15% |
|
| Perez Jeffrey Thomas |
SVP, IP Affairs |
• – – |
2023-08-24 |
4 |
AS |
$1.64 |
$14,581 |
D/D |
(8,891) |
458,903 |
|
-15% |
|
| Shah Rutul R |
Chief Operating Officer |
• – – |
2023-08-24 |
4 |
AS |
$1.64 |
$8,836 |
D/D |
(5,388) |
133,474 |
|
-15% |
|
| Lehr Donald P. |
Chief Legal Officer |
• – – |
2023-08-24 |
4 |
AS |
$1.64 |
$17,953 |
D/D |
(10,947) |
428,916 |
|
-15% |
|
| Thomasian Harry Jr. |
Chief Financial Officer |
• – – |
2023-08-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,934 |
170,096 |
|
- |
|
| Perez Jeffrey Thomas |
SVP, IP Affairs |
• – – |
2023-08-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,878 |
467,794 |
|
- |
|
| Shah Rutul R |
Chief Operating Officer |
• – – |
2023-08-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,480 |
138,862 |
|
- |
|
| Sabzevari Helen |
President and CEO |
• • – |
2023-08-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
141,587 |
1,636,973 |
|
- |
|
| Lehr Donald P. |
Chief Legal Officer |
• – – |
2023-08-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,710 |
439,863 |
|
- |
|
| Sabzevari Helen |
President and CEO |
• • – |
2023-08-18 |
4 |
AS |
$1.66 |
$92,719 |
D/D |
(55,855) |
1,495,386 |
|
-13% |
|
| Perez Jeffrey Thomas |
SVP, IP Affairs |
• – – |
2023-08-17 |
4 |
AS |
$1.55 |
$13,549 |
D/D |
(8,741) |
448,916 |
|
-22% |
|
| Shah Rutul R |
Chief Operating Officer |
• – – |
2023-08-17 |
4 |
AS |
$1.55 |
$8,212 |
D/D |
(5,298) |
123,382 |
|
-22% |
|
| Lehr Donald P. |
Chief Legal Officer |
• – – |
2023-08-17 |
4 |
AS |
$1.55 |
$16,681 |
D/D |
(10,762) |
418,153 |
|
-22% |
|
| Thomasian Harry Jr. |
Chief Financial Officer |
• – – |
2023-08-17 |
4 |
AS |
$1.55 |
$13,784 |
D/D |
(8,893) |
152,162 |
|
-22% |
|
| Sabzevari Helen |
President and CEO |
• • – |
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
141,587 |
1,551,241 |
|
- |
|
| Perez Jeffrey Thomas |
SVP, IP Affairs |
• – – |
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,878 |
457,657 |
|
- |
|
| Shah Rutul R |
Chief Operating Officer |
• – – |
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,480 |
128,680 |
|
- |
|
689 Records found
|
|
Page 2 of 28 |
|
|
0.02 (1.55%) 
